-
公开(公告)号:AU4755293A
公开(公告)日:1994-03-31
申请号:AU4755293
申请日:1993-09-23
Applicant: HOECHST AG
Inventor: JAHNE GERHARD , HELSBERG MATTHIAS , WINKLER IRVIN , GROSS GREHARD , SCHOLL THOMAS
IPC: A61K31/505 , A61P31/12 , C07D487/04 , C07F9/6561
Abstract: Compounds of the formula I in which the substituents X, Y, R , R and R have the meanings mentioned, have antiviral activity.
-
公开(公告)号:HU9302699D0
公开(公告)日:1993-12-28
申请号:HU9302699
申请日:1993-09-24
Applicant: HOECHST AG
Inventor: JAHNE GERHARD , HELSBERG MATTHIAS , WINKLER IRVIN , GROSS GERHARD , SCHOLL THOMAS
IPC: A61K31/505 , A61P31/12 , C07D487/04 , C07F9/6561
Abstract: Compounds of the formula I in which the substituents X, Y, R , R and R have the meanings mentioned, have antiviral activity.
-
公开(公告)号:NO931134A
公开(公告)日:1993-09-29
申请号:NO931134
申请日:1993-03-26
Applicant: HOECHST AG
Inventor: JAEHNE GERHARD , HELSBERG MATTHIAS , WINKLER IRVIN , GROSS GERHARD , SCHOLL THOMAS
IPC: A61K31/52 , A61P31/12 , C07D473/00 , C07D473/32
CPC classification number: C07D473/32
-
公开(公告)号:NO933396D0
公开(公告)日:1993-09-23
申请号:NO933396
申请日:1993-09-23
Applicant: HOECHST AG
Inventor: JAEHNE GERHARD , HELSBERG MATTHIAS , WINKLER IRVIN , GROSS GERHARD , SCHOLL THOMAS
IPC: A61K31/505 , A61P31/12 , C07D487/04 , C07F9/6561 , C07D
Abstract: Compounds of the formula I in which the substituents X, Y, R , R and R have the meanings mentioned, have antiviral activity.
-
15.
公开(公告)号:ZA9300423B
公开(公告)日:1993-09-09
申请号:ZA93423
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , O'MALLEY GERARD , WINKLER IRVIN , PEYMAN ANUSCHIRWAN , HELSBERG MATTHIAS
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/24 , C07F9/44 , C07H21/00 , C07H21/04 , C12Q1/68 , C07H , A61K , C12Q
CPC classification number: C07H21/00
-
公开(公告)号:HUT63172A
公开(公告)日:1993-07-28
申请号:HU9300161
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERALD , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/24 , C07F9/44 , C07H21/00 , C07H21/04 , C12Q1/68 , C07H19/20 , C07H19/10
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R = H, a substituent or -P(=W)ZZ'; R = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R , R = substituents; p = 1-100; q = 0-18; R = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta or a group of formula (ii); alpha = 1-11; beta = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha or beta configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR R ); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R , R = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
-
公开(公告)号:NO930199A
公开(公告)日:1993-07-23
申请号:NO930199
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERARD , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/22 , C07F9/24 , C07H1/00 , C07H21/00 , C07H21/04 , C12Q1/68 , C07H19/20 , C07H19/10
CPC classification number: C07H21/00 , C07B2200/11
-
公开(公告)号:CA2087818A1
公开(公告)日:1993-07-23
申请号:CA2087818
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERARD , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/22 , C07F9/24 , C07H1/00 , C07H21/00 , C07H21/04 , C12Q1/68 , C07F9/48 , C07F9/553
Abstract: HOE 92/F 012 of the disclosure Oligonucleotide analogs, their preparation and use The invention relates to compounds of the formula I (I) where R1 is H, alkyl, acyl, aryl or a phosphate residue; R2 is H, OH, alkoxy, NH2 or halogen; B is a base customary in nucleotide chemistry; a is O or CH2; n is an integer from 1 to 100; W = O, S or Se; V = O, S or NH; Y = O, S, NH or CH2; Y' = O, S, NH or alkylene; X = OH or SH; U = OH, SH, SeH, alkyl, aryl or amine and Z = OH, SH, SeH, an optionally substituted radical from the group comprising alkyl, aryl, heteroaryl, alkoxy or amino, or a group which favors intracellular uptake or serves as the label of a DNA probe or attacks the target nucleic acid during hybridization, where if Z = OH, SH, CH3 or OC2H5, at least one of the groups X, Y, Y', V or W is not OH or O or R1 is not H; a process for their preparation and their use as inhibitors of gene expression, as probes for detecting nucleic acids and as aids in molecular biology.
-
公开(公告)号:HU9300161D0
公开(公告)日:1993-04-28
申请号:HU9300161
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERALD , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/24 , C07F9/44 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R = H, a substituent or -P(=W)ZZ'; R = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R , R = substituents; p = 1-100; q = 0-18; R = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta or a group of formula (ii); alpha = 1-11; beta = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha or beta configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR R ); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R , R = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
-
公开(公告)号:NO931134D0
公开(公告)日:1993-03-26
申请号:NO931134
申请日:1993-03-26
Applicant: HOECHST AG
Inventor: JAEHNE GERHARD , HELSBERG MATTHIAS , WINKLER IRVIN , GROSS GERHARD , SCHOLL THOMAS
IPC: A61K31/52 , A61P31/12 , C07D473/00 , C07D473/32 , C07D
Abstract: Compounds of the formula 1 in which the radicals R and/or R independently of one another represent acyl radicals of the formula -C(=O)-R (2> where R denotes C1-C3-alkyl and one of the radicals R and R can also denote hydrogen, and their physiologically tolerable salts have an antiviral action.
-
-
-
-
-
-
-
-
-